ClinicalTrials.Veeva

Menu

Minimally Invasive Hypoglossal Nerve Stimulation Study (Lingual Study)

Medtronic logo

Medtronic

Status

Completed

Conditions

Sleep Apnea, Obstructive

Treatments

Procedure: Transvenous hypoglossal nerve stimulation

Study type

Interventional

Funder types

Industry

Identifiers

NCT03210142
MDT16057

Details and patient eligibility

About

The purpose of this study is to assess the effect of Transvenous Hypoglossal Nerve Stimulation (tHGNS) on tongue position in the upper airway. Activation of the HGN will cause contraction of the genioglossus muscle, which will move the tongue forward, opening the upper-airway and reducing apnea-hypopnea events in patients with Obstructive Sleep Apnea (OSA). A transvenous approach will be less risky and traumatic than current HGNS systems that require an open surgical approach to wrap a cuff electrode around the HGN.

Full description

The primary objective is to determine the effect of tHGNS on tongue position in the upper airway in subjects undergoing an EP, cardiac catheterization or device procedure. (Measured as changes in the anteroposterior dimensions (2-dimensional) of the retropalatal and retrolingual airway spaces.) This will be an acute study lasting no more than 45 min during a standard new device implant, cardiac catheterization and/or EP procedure. The hypoglossal nerve will be stimulated from the lingual vein using various stimulation parameters. Tongue motion, upper airway opening or any side effects will be recorded. At the end of the test procedure all hardware - the catheters, lead and/or guide wire will be removed.

Enrollment

23 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject is at least 18 years old
  • Subject is undergoing a standard new device implant, cardiac catheterization involving right heart catheterization and/or EP procedures
  • Subject is able and willing to give informed consent

Exclusion criteria

  • Subject is unable or unwilling to participate with study procedures
  • Subject is pregnant (all women with childbearing potential must have a negative pregnancy test within 7 days prior to enrollment)
  • Subject is known to be allergic to radio opaque dye
  • Subject has a body mass index (BMI) >40 kg/m2
  • Subject has had prior neck surgery that may interfere with vascular access to the lingual vein
  • Subject has had prior surgery of the oral cavity that may interfere with tongue or soft palate movement
  • Subject has a significant upper airway-related anatomic anomaly
  • Subject is enrolled in a concurrent study that may confound the results of this study.

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

23 participants in 1 patient group

Transvenous hypoglossal nerve stimulation
Experimental group
Description:
Transvenous hypoglossal nerve stimulation for subjects undergoing an EP, cardiac catheterization or device procedure.
Treatment:
Procedure: Transvenous hypoglossal nerve stimulation

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems